These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 932225)

  • 1. Conditions for collection of serum samples for the measurement of fibrin(ogen) degradation products by radioimmunoassay of fragment E.
    Martin MJ; Gordon YB; Ratky SM; Baker LR; Chard T
    J Clin Pathol; 1976 Apr; 29(4):336-40. PubMed ID: 932225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of specimen collection on routine coagulation assays and D-dimer measurement.
    Lippi G; Guidi GC
    Clin Chem; 2004 Nov; 50(11):2150-2. PubMed ID: 15502084
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.
    Bini A; Fenoglio JJ; Mesa-Tejada R; Kudryk B; Kaplan KL
    Arteriosclerosis; 1989; 9(1):109-21. PubMed ID: 2643421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies.
    Nieuwenhuizen W
    Blut; 1988 Nov; 57(5):285-91. PubMed ID: 3058234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive latex slide assay for fibrin(ogen) fragment E.
    Carney JA; Knight I; Lane DA
    Clin Chim Acta; 1985 Apr; 147(2):173-7. PubMed ID: 3987062
    [No Abstract]   [Full Text] [Related]  

  • 6. No influence of heparin plasma and other (pre)analytic variables on D-dimer determinations.
    Schutgens RE; Haas FJ; Ruven HJ; Spannagl M; Horn K; Biesma DH
    Clin Chem; 2002 Sep; 48(9):1611-3. PubMed ID: 12194950
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood coagulation after long distance running: antithrombin III prevents fibrin formation.
    Bärtsch P; Haeberli A; Straub PW
    Thromb Haemost; 1990 Jun; 63(3):430-4. PubMed ID: 2402746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-analytical variation in the measurements of sensitive markers of coagulation and fibrinolysis: the influence of venipuncture and mixing of blood.
    Iversen LH
    Haemostasis; 1997; 27(3):119-24. PubMed ID: 9306128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of serum fibrinogen degradation products using gel chromatography and radioimmunoassay.
    Ratky SM; Sykes A; Cooke ED; Gordon YB
    Thromb Haemost; 1977 Jun; 37(3):471-6. PubMed ID: 578027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of preanalytical errors due to in vitro activation of coagulation.
    Bartels PC; Schoorl M; van Bodegraven AA
    Clin Lab; 2001; 47(9-10):449-52. PubMed ID: 11596906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing fibrin-split products.
    Norris MK
    Nursing; 1992 Jun; 22(6):29. PubMed ID: 1614647
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of temperature and time before centrifugation of specimens for routine coagulation testing.
    Salvagno GL; Lippi G; Montagnana M; Franchini M; Poli G; Guidi GC
    Int J Lab Hematol; 2009 Aug; 31(4):462-7. PubMed ID: 18371059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it acceptable to use coagulation plasma samples stored at room temperature and 4°C for 24 hours for additional prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin, and D-dimer testing?
    Rimac V; Coen Herak D
    Int J Lab Hematol; 2017 Oct; 39(5):475-481. PubMed ID: 28488785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum levels of fibrin (ogen) degradation fragment E antigen in the diagnosis of deep vein thrombosis after abdominal and inguinal surgery.
    Butler MJ; Gordon YB; Irving MH; Sola CM; Chard T
    Thromb Res; 1976 Feb; 8(2):167-71. PubMed ID: 1251348
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of freezing plasma at -20°C for 2 weeks on prothrombin time, activated partial thromboplastin time, dilute Russell viper venom time, activated protein C resistance, and D-dimer levels.
    Foshat M; Bates S; Russo W; Huerta A; Albright K; Giddings K; Indrikovs A; Qian YW
    Clin Appl Thromb Hemost; 2015 Jan; 21(1):41-7. PubMed ID: 24842886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clot activators and anticoagulant additives for blood collection. A critical review on behalf of COLABIOCLI WG-PRE-LATAM.
    Lima-Oliveira G; Brennan-Bourdon LM; Varela B; Arredondo ME; Aranda E; Flores S; Ochoa P
    Crit Rev Clin Lab Sci; 2021 May; 58(3):207-224. PubMed ID: 33929278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure.
    Henderson SJ; Xia J; Wu H; Stafford AR; Leslie BA; Fredenburgh JC; Weitz DA; Weitz JI
    Thromb Haemost; 2016 Mar; 115(3):533-42. PubMed ID: 26489782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.